Literature DB >> 16651633

Osteopontin expression in intratumoral astrocytes marks tumor progression in gliomas induced by prenatal exposure to N-ethyl-N-nitrosourea.

Taichang Jang1, Todd Savarese, Hoi Pang Low, Sunchin Kim, Hannes Vogel, David Lapointe, Timothy Duong, N Scott Litofsky, James M Weimann, Alonzo H Ross, Lawrence Recht.   

Abstract

To better study early events in glioma genesis, markers that reliably denote landmarks in glioma development are needed. In the present study, we used microarray analysis to compare the gene expression patterns of magnetic resonance imaging (MRI)-localized N-ethyl-N-nitrosourea (ENU)-induced tumors in rat brains with those of uninvolved contralateral side and normal brains. Our analysis identified osteopontin (OPN) as the most up-regulated gene in glioma. Using immunohistochemistry we then confirmed OPN expression in every tumor examined (n = 17), including those with diameters as small as 300 mum. By contrast, no OPN immunostaining was seen in normal brain or in brains removed from ENU-exposed rats before the development of glioma. Further studies confirmed that OPN was co-localized exclusively in intratumoral glial fibrillary acidic protein-expressing cells and was notably absent from nestin-expressing ones. In conjunction with this, we confirmed that both normal neurosphere cells and ENU-im-mortalized subventricular zone/striatal cells produced negligible amounts of OPN compared to the established rat glioma cell line C6. Furthermore, inducing OPN expression in an immortalized cell line increased cell proliferation. Based on these findings, we conclude that OPN overexpression in ENU-induced gliomas occurs within a specific subset of intratumoral glial fibrillary acidic protein-positive cells and becomes evident at the stage of tumor progression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16651633      PMCID: PMC1606608          DOI: 10.2353/ajpath.2006.050400

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  56 in total

1.  A sequential ultrastructural and histoautoradiographic study of early neoplastic lesions in ethylnitrosourea-induced rat glioma.

Authors:  T Ikeda; H Mashimoto; K Iwasaki; I Shimokawa; T Matsuo
Journal:  Acta Pathol Jpn       Date:  1989-08

2.  Clonal analysis of gliomas.

Authors:  M M Kattar; W J Kupsky; R K Shimoyama; T D Vo; M W Olson; G R Bargar; F H Sarkar
Journal:  Hum Pathol       Date:  1997-10       Impact factor: 3.466

3.  Magnetic resonance imaging of ethyl-nitrosourea-induced rat gliomas: a model for experimental therapeutics of low-grade gliomas.

Authors:  P E Kish; M Blaivas; M Strawderman; K M Muraszko; D A Ross; B D Ross; G McMahon
Journal:  J Neurooncol       Date:  2001-07       Impact factor: 4.130

Review 4.  Commentary: is the concept of "tumor promotion" a useful paradigm?

Authors:  J E Trosko
Journal:  Mol Carcinog       Date:  2001-03       Impact factor: 4.784

5.  Isolation of immortalized, INK4a/ARF-deficient cells from the subventricular zone after in utero N-ethyl-N-nitrosourea exposure.

Authors:  Todd M Savarese; Taichang Jang; Hoi Pang Low; Rebecca Salmonsen; N Scott Litofsky; Zdenka Matuasevic; Alonzo H Ross; Lawrence D Recht
Journal:  J Neurosurg       Date:  2005-01       Impact factor: 5.115

6.  Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling.

Authors:  Deepak Agrawal; Tingan Chen; Rosalyn Irby; John Quackenbush; Ann F Chambers; Marianna Szabo; Alan Cantor; Domenico Coppola; Timothy J Yeatman
Journal:  J Natl Cancer Inst       Date:  2002-04-03       Impact factor: 13.506

7.  Osteopontin expression and distribution in human carcinomas.

Authors:  L F Brown; A Papadopoulos-Sergiou; B Berse; E J Manseau; K Tognazzi; C A Perruzzi; H F Dvorak; D R Senger
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

8.  The development of experimental brain tumours a sequential light and electron microscope study of the subependymal plate. II. Microtumours.

Authors:  G J Pilkington; P L Lantos
Journal:  Acta Neuropathol       Date:  1979-03-15       Impact factor: 17.088

9.  Secreted phosphoproteins associated with neoplastic transformation: close homology with plasma proteins cleaved during blood coagulation.

Authors:  D R Senger; C A Perruzzi; C F Gracey; A Papadopoulos; D G Tenen
Journal:  Cancer Res       Date:  1988-10-15       Impact factor: 12.701

10.  A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice.

Authors:  E C Holland; W P Hively; R A DePinho; H E Varmus
Journal:  Genes Dev       Date:  1998-12-01       Impact factor: 11.361

View more
  22 in total

1.  Osteopontin is up-regulated and associated with neutrophil and macrophage infiltration in glioblastoma.

Authors:  Nadia A Atai; Manju Bansal; Cheungh Lo; Joost Bosman; Wikky Tigchelaar; Klazien S Bosch; Ard Jonker; Philip C De Witt Hamer; Dirk Troost; Christopher A McCulloch; Vincent Everts; Cornelis J F Van Noorden; Jaro Sodek
Journal:  Immunology       Date:  2010-08-17       Impact factor: 7.397

2.  Anti-inflammatory effects of thymoquinone in activated BV-2 microglial cells.

Authors:  Equar Taka; Elizabeth A Mazzio; Carl B Goodman; Natalie Redmon; Hernan Flores-Rozas; Renee Reams; Selina Darling-Reed; Karam F A Soliman
Journal:  J Neuroimmunol       Date:  2015-06-27       Impact factor: 3.478

Review 3.  Inhibiting vasculogenesis after radiation: a new paradigm to improve local control by radiotherapy.

Authors:  Brown J Martin
Journal:  Semin Radiat Oncol       Date:  2013-10       Impact factor: 5.934

Review 4.  Vasculogenesis: a crucial player in the resistance of solid tumours to radiotherapy.

Authors:  J M Brown
Journal:  Br J Radiol       Date:  2014-03       Impact factor: 3.039

5.  Regulatory effect of nerve growth factor in alpha9beta1 integrin-dependent progression of glioblastoma.

Authors:  Meghan C Brown; Izabela Staniszewska; Philip Lazarovici; George P Tuszynski; Luis Del Valle; Cezary Marcinkiewicz
Journal:  Neuro Oncol       Date:  2008-12       Impact factor: 12.300

6.  Wnt/beta-catenin/Tcf signaling pathway activation in malignant progression of rat gliomas induced by transplacental N-ethyl-N-nitrosourea exposure.

Authors:  Gangadhara Reddy Sareddy; Sundaram Challa; Manas Panigrahi; Phanithi Prakash Babu
Journal:  Neurochem Res       Date:  2009-01-16       Impact factor: 3.996

7.  Involvement of osteopontin as a core protein in craniopharyngioma calcification formation.

Authors:  SongTao Qi; GuangLong Huang; Jun Pan; Jia Li; Xi'An Zhang; LuXiong Fang; BaoGuo Liu; Wei Meng; YongMing Zhang; XiaoJun Liu
Journal:  J Neurooncol       Date:  2009-11-10       Impact factor: 4.130

8.  Osteopontin regulates human glioma cell invasiveness and tumor growth in mice.

Authors:  Hsun-Jin Jan; Chin-Cheng Lee; Yung-Luen Shih; Dueng-Yuan Hueng; Hsin-I Ma; Jing-Huei Lai; Hen-Wei Wei; Horng-Mo Lee
Journal:  Neuro Oncol       Date:  2009-12-23       Impact factor: 12.300

9.  Correlation between osteopontin protein expression and histological grade of astrocytomas.

Authors:  H Toy; O Yavas; O Eren; M Genc; C Yavas
Journal:  Pathol Oncol Res       Date:  2008-12-02       Impact factor: 3.201

10.  Osteopontin expression correlates with angiogenesis and survival in malignant astrocytoma.

Authors:  Koviljka Matusan-Ilijas; Senija Behrem; Nives Jonjic; Kamelija Zarkovic; Ksenija Lucin
Journal:  Pathol Oncol Res       Date:  2008-05-21       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.